InCellDx Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
InCellDx General Information
Description
Developer of precision diagnostic technology intended to diagnose and treat chronic inflammatory diseases through machine learning and AI-based precision diagnostics. The company offers precision diagnostics, diagnostic testing, pharmaceutical treatments, health data platforms, telemedicine services, and biometric monitoring, enabling patients to undergo diagnosis, treatment, and management of chronic inflammatory diseases.
Contact Information
Website
www.healthbio.comCorporate Office
- 30920 Huntwood Avenue
- Hayward, CA 94544
- United States
Corporate Office
- 30920 Huntwood Avenue
- Hayward, CA 94544
- United States
InCellDx Timeline
InCellDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Feb-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 23-Jul-2024 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Later Stage VC (Series A1) | 08-Jan-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 10-May-2012 | $6M | $9M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 15-Jun-2010 | $3M | $3M | Completed | Startup |
InCellDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
InCellDx Comparisons
Industry
Financing
Details
InCellDx Competitors (43)
One of InCellDx’s 43 competitors is Foundation Medicine, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Hain Lifescience | Corporate Backed or Acquired | Nehren, Germany | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| TopoGen | Corporation | Buena Vista, CO | ||||
| AusDiagnostics | Formerly PE-Backed | Mascot, Australia |
InCellDx Patents
InCellDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4754535-A1 | Methods of assigning a covid pathological type and compositions for practicing the same, and methods of treating a subject for chronic covid-19 | Pending | 01-Aug-2023 | ||
| WO-2025029797-A1 | Methods of assigning a covid pathological type and compositions for practicing the same, and methods of treating a subject for chronic covid-19 | Inactive | 01-Aug-2023 | ||
| WO-2023192361-A1 | Methods of treating a subject for fibromyalgia and compositions for use in the same | Inactive | 31-Mar-2022 | ||
| EP-4499098-A1 | Methods of treating a subject for myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) and compositions for use in the same | Pending | 31-Mar-2022 | ||
| EP-4499098-A4 | Methods of treating a subject for myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) and compositions for use in the same | Pending | 31-Mar-2022 | A61K31/46 |
InCellDx Signals
InCellDx Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boomerang Catapult | Venture Capital | Minority | ||
| Stony Lonesome Group | Venture Capital | Minority |
InCellDx FAQs
-
When was InCellDx founded?
InCellDx was founded in 2009.
-
Where is InCellDx headquartered?
InCellDx is headquartered in Hayward, CA.
-
What is the size of InCellDx?
InCellDx has 22 total employees.
-
What industry is InCellDx in?
InCellDx’s primary industry is Biotechnology.
-
Is InCellDx a private or public company?
InCellDx is a Private company.
-
What is InCellDx’s current revenue?
The current revenue for InCellDx is .
-
How much funding has InCellDx raised over time?
InCellDx has raised $20M.
-
Who are InCellDx’s investors?
Boomerang Catapult and Stony Lonesome Group have invested in InCellDx.
-
Who are InCellDx’s competitors?
Foundation Medicine, Hain Lifescience, Illumina, TopoGen, and AusDiagnostics are some of the 43 competitors of InCellDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process